Among 275 patients with COVID-19, we found that median blood zinc level was significantly lower in patients with poor clinical outcome (N = 75) as compared to patients with good clinical outcome (N = 200) (840 μg/L versus 970 μg/L; p < 0.0001), suggesting that zinc supplementation could be useful for patients with severe COVID-19.
Keywords: Azithromycin; Chloroquine; Clinical outcome; SARS-COV-2; Severe; Zinc.
Copyright © 2021. Published by Elsevier B.V.